United StatesOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 265 out of 360,881 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 2,913 | 3,017 |
| Total Cites | 77,418 | 85,872 |
| H-index | 130 | 136 |
| Hm-index | 53 | 55 |
| Number of Single Authored Papers | 55 | 55 |
| Total Cites to Single Authored Papers | 499 | 539 |
| Number of Single+First Authored Papers | 95 | 95 |
| Total Cites to Single+First Authored Papers | 3,255 | 3,441 |
| Number of Single+First+Last Authored Papers | 331 | 331 |
| Total Cites to Single+First+Last Authored Papers | 22,461 | 24,375 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 51,502 | 54,592 |
| Ratio of Total Citations to Distinct Citing Papers | 1.50 | 1.57 |
| Self-Citation Percentage |
9.84%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 273 out of 323,273 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 2,857 | 2,921 |
| Total Cites | 66,234 | 73,719 |
| H-index | 123 | 131 |
| Hm-index | 50 | 52 |
| Number of Single Authored Papers | 55 | 55 |
| Total Cites to Single Authored Papers | 459 | 499 |
| Number of Single+First Authored Papers | 94 | 94 |
| Total Cites to Single+First Authored Papers | 3,058 | 3,239 |
| Number of Single+First+Last Authored Papers | 317 | 317 |
| Total Cites to Single+First+Last Authored Papers | 19,581 | 21,283 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 44,246 | 47,016 |
| Ratio of Total Citations to Distinct Citing Papers | 1.50 | 1.57 |
| Self-Citation Percentage |
10.15%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 265 out of 305,851 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 2,803 | 2,867 |
| Total Cites | 59,862 | 66,701 |
| H-index | 118 | 127 |
| Hm-index | 48 | 51 |
| Number of Single Authored Papers | 55 | 55 |
| Total Cites to Single Authored Papers | 435 | 474 |
| Number of Single+First Authored Papers | 94 | 94 |
| Total Cites to Single+First Authored Papers | 2,944 | 3,120 |
| Number of Single+First+Last Authored Papers | 299 | 299 |
| Total Cites to Single+First+Last Authored Papers | 17,928 | 19,445 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 40,013 | 42,579 |
| Ratio of Total Citations to Distinct Citing Papers | 1.50 | 1.57 |
| Self-Citation Percentage |
10.25%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 273 out of 278,898 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 2,889 | 2,937 |
| Total Cites | 56,790 | 63,360 |
| H-index | 114 | 124 |
| Hm-index | 47 | 50 |
| Number of Single Authored Papers | 55 | 55 |
| Total Cites to Single Authored Papers | 404 | 442 |
| Number of Single+First Authored Papers | 94 | 94 |
| Total Cites to Single+First Authored Papers | 2,817 | 2,988 |
| Number of Single+First+Last Authored Papers | 296 | 296 |
| Total Cites to Single+First+Last Authored Papers | 17,018 | 18,486 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 38,051 | 40,500 |
| Ratio of Total Citations to Distinct Citing Papers | 1.49 | 1.56 |
| Self-Citation Percentage |
10.37%
|
|
Trending Researchers
.jpeg)
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.